WHARTEXA 5B HUC-MSCs Exosome
Whartexa 5B HUC-MSCs Exosome is a specialized regenerative extracellular vesicle formulation developed by Nanoventra as part of the proprietary Whartexa Line.
​
​Derived from carefully processed Wharton’s Jelly Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs), this advanced exosome system is engineered using precision isolation and preservation technologies designed to support extracellular vesicle integrity, biological consistency, and regenerative signaling potential.
Human-Derived Exosomes From:*
Wharton’s Jelly
Product image shown represents the finalized Whartexa formulation. Actual presentation may vary slightly depending on packaging updates, preservation configuration, and production optimization protocols.
Details
Quality
Related Products
Details
WHARTEXA 5B HUC-MSCs Exosome
Nanoventra provides advanced HUC-MSC-derived extracellular vesicle systems developed through controlled isolation, purification, and cryopreservation methodologies designed to preserve vesicle stability and biological signaling consistency.
​
Whartexa 5B is developed from carefully processed Wharton’s Jelly umbilical biological sources and represents an entry-level concentration within the proprietary Whartexa regenerative platform.
​
This formulation is optimized for professional regenerative integration workflows requiring controlled extracellular vesicle handling, laboratory-grade consistency, and advanced nano-vesicle preparation standards.
​
Human umbilical cord-derived extracellular vesicles are widely studied for their regenerative signaling relevance and their emerging role within modern regenerative biotechnology, aesthetic integration systems, and cellular communication research.
Key Features
-
Proprietary Whartexa regenerative exosome platform
-
Human Wharton’s Jelly HUC-MSC-derived extracellular vesicles
-
5 Billion particle concentration system
-
Advanced purification and vesicle isolation methodologies
-
Controlled laboratory-grade preparation workflows
-
Cryopreserved formulation maintained at −20°C
-
Optimized vesicle integrity and biological consistency
-
Professional regenerative and biotechnology-oriented integration
-
Research-focused extracellular vesicle preparation standards
-
Advanced nano-vesicle handling and preservation protocols
Quality
Specifications
All Whartexa 5B HUC-MSCs Exosome formulations undergo controlled scientific quality verification through multi-stage laboratory handling and extracellular vesicle processing protocols.
Each preparation is processed under sterile laboratory-oriented conditions with attention to:
-
vesicle integrity
-
biological consistency
-
extracellular particle stability
-
purification precision
-
advanced handling reproducibility
Nanoventra applies biotechnology-grade quality methodologies intended to support consistency across regenerative extracellular vesicle preparation systems.
The Whartexa Line represents Nanoventra’s premium exosome technology division focused on advanced extracellular vesicle refinement and controlled regenerative formulation development.
Storage & Handling
-
Recommended storage temperature: −20°C
-
Maintain cryopreserved conditions during handling
-
Avoid repeated freeze-thaw exposure
-
Professional laboratory-oriented handling recommended